Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CSPC Pharmaceutical Group ( (HK:1093) ) has provided an announcement.
CSPC Pharmaceutical Group announced the on-market purchase of 4,496,000 shares as part of its restricted share award scheme. This move, representing approximately 0.039% of the total shares in issue, is intended to benefit selected participants and reflects the company’s ongoing commitment to employee incentives and shareholder value.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 171,429,409
Technical Sentiment Signal: Buy
Current Market Cap: HK$104.7B
See more insights into 1093 stock on TipRanks’ Stock Analysis page.